These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8718812)

  • 21. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin.
    Perna AF; Castaldo P; Ingrosso D; De Santo NG
    J Nephrol; 1999; 12(4):230-40. PubMed ID: 10493566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
    Wilcken DE
    J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine: a new risk factor for atherosclerosis.
    Fallest-Strobl PC; Koch DD; Stein JH; McBride PE
    Am Fam Physician; 1997 Oct; 56(6):1607-12, 1615-6. PubMed ID: 9351429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
    Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinemia and lower extremity wounds.
    Schwartzfarb EM; Romanelli P
    Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of diet on endothelial function.
    Davis N; Katz S; Wylie-Rosett J
    Cardiol Rev; 2007; 15(2):62-6. PubMed ID: 17303992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homocysteine and endothelial vascular function.
    Hanratty CG; McAuley DF; McGurk C; Young IS; Johnston GD
    Lancet; 1998 Apr; 351(9111):1288-9. PubMed ID: 9643777
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute hyperhomocysteinaemia and endothelial dysfunction.
    Chambers JC; McGregor A; Jean-Marie J; Kooner JS
    Lancet; 1998 Jan; 351(9095):36-7. PubMed ID: 9433433
    [No Abstract]   [Full Text] [Related]  

  • 31. [Homocysteine as a nonlipid factor in the pathogenesis of atherosclerosis].
    Magott M
    Postepy Hig Med Dosw; 1998; 52(3):259-67. PubMed ID: 9789435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperhomocysteinemia--a risk factor in atherosclerosis].
    Marković N; Stefanović V
    Srp Arh Celok Lek; 1999; 127(9-10):326-32. PubMed ID: 10649903
    [No Abstract]   [Full Text] [Related]  

  • 33. Homocysteine in myointimal hyperplasia.
    Hansrani M; Gillespie JI; Stansby G
    Eur J Vasc Endovasc Surg; 2002 Jan; 23(1):3-10. PubMed ID: 11748941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Homocysteine: a cardiovascular risk factor?].
    Suter PM; Häsler E; Locher R; Vetter W
    Praxis (Bern 1994); 1999 Feb; 88(7):259-72. PubMed ID: 10097646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vascular endothelial dysfunctions, possible detection and treatment].
    Sejda T
    Vnitr Lek; 2000 Jul; 46(7):403-7. PubMed ID: 15635802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction in the pathogenesis of atherosclerosis.
    Poredos P
    Int Angiol; 2002 Jun; 21(2):109-16. PubMed ID: 12110769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible hypertension following coeliac disease treatment: the role of moderate hyperhomocysteinaemia and vascular endothelial dysfunction.
    Lim PO; Tzemos N; Farquharson CA; Anderson JE; Deegan P; MacWalter RS; Struthers AD; MacDonald TM
    J Hum Hypertens; 2002 Jun; 16(6):411-5. PubMed ID: 12037696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine: predictor of thrombotic disease.
    Macy PA
    Clin Lab Sci; 2001; 14(4):272-5. PubMed ID: 11760827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate, homocysteine, endothelial function and cardiovascular disease.
    Moat SJ; Lang D; McDowell IF; Clarke ZL; Madhavan AK; Lewis MJ; Goodfellow J
    J Nutr Biochem; 2004 Feb; 15(2):64-79. PubMed ID: 14972346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Moderate hyperhomocysteinemia and atherothrombosis].
    Falcón CR
    Medicina (B Aires); 1998; 58(5 Pt 1):511-4. PubMed ID: 9922487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.